- Home
- Automated
- NDF A-Z listing
- Botulinum Antitoxin
B
Botulinum Antitoxin
Subsidy Information and Financing Scheme
No
Drug Guidance
No
Post-marketing information
No
Summary of Biologics
No
Active ingredient: Botulinum Antitoxin
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Drug availability
Formulation | Public Healthcare Institution |
|---|---|
BAT Injection, Solution, Botulism Antitoxin (Equine) Serotype A > 4,500 units/vial + Botulism Antitoxin (Equine) Serotype B > 3,300 units/vial + Botulism Antitoxin (Equine) Serotype C > 3,000 units/vial + Botulism Antitoxin (Equine) Serotype D > 600 units/vial + Botulism Antitoxin (Equine) Serotype E > 5,100 units/vial + Botulism Antitoxin (Equine) Serotype F > 3,000 units/vial + Botulism Antitoxin (Equine) Serotype G > 600 units/vial |
|